drugs acting on uterus
TRANSCRIPT
.
1
Drugs acting on UterusXYTOCICS & T COLYTICS
1
Dr. Shipra JainAssociate Professor,
Dept. of Pharmacology
OXYTOCICS
▪Oxytocics are the drugs that have the power to stimulate
the contraction of uterine muscles.
▪Also called Uterotonics
▪The introduction of oxytocic drugs for the treatment of
Post Partum Hemorrhage (PPH) has been regarded as
“one of the enduring achievements of modern science”
(Moir, 1964)
2
Oxytocics / Ecbolics/ Abortifacients /
Uterine stimulants
1. Posterior Pituitary hormones - Oxytocin, Carbetocin,
Vasopressin
2. Ergot alkaloids - Ergometrine/Ergonovine,
Methylergometrine
3. Prostaglandins - PGE2, PGF2α, Misoprostol
4. Miscellaneous – Quinine, Emetine, Alcohol, Ethacridine
3
Oxytocin
4
Oxytocin
Hormone of Posterior pituitary.
The other hormone is vasopressin
5
Oxytocin( Hormone of love, cuddle chemical )
▪A nonapeptide.
▪First synthesized by Vincent du Vigneaud in
1953, for which he was awarded Nobel Prize in
Chemistry in 1955.
6
.
2
Biosynthesis
▪Synthesized in cell bodies of supraoptic & paraventricular nucleus of hypothalumus as prohormone
▪Packaged into the secretory granules by oxytocin-neurophysin complex
▪Secreted from nerve endings in posterior pituitary gland (neurohypophysis)
▪Oxytocinergic nerves project to hypothalumus, brain stem and spinal chord
▪Luteal cells of ovary and fetal membranes synthesize oxytocin
7 8
Oxytocin secretion
▪Sensory stimuli from cervix, vagina and breast suckling
▪Oestrogen increases its secretion
▪Progesterone decreases its secretion
▪Ovarian polypeptide relaxin inhibits its release
▪Pain, haemorrhage and dehydration increases secretion
9
Physiological Role
UTERUS
▪ Increase in force and frequency of contractions
▪Full relaxation occurs in between the contractions at low doses
▪Very low level of motor activity in the first two trimesters
▪3rd trimester – spontaneous motor activity progressively increases and sharp rise initiates labor
▪Exogenous oxytocin can initiate rhythmic contractions
10
▪8 fold increase in uterine sensitivity in last 9 weeks and 30 fold increase in number of oxytocin receptors between early pregnancy and early labor – estrogen
▪ Increase in contraction is restricted to fundus and the body
▪Non pregnant uterus is resistant to its action
▪Oxytocin antagonist ATOSIBAN suppresses preterm labor
11
Oxytocin
Mechanism of action:
▪Acts through oxytocin receptors present in smooth
muscles of myometrium.
▪Stimulates the amniotic and decidual prostaglandin
production.
▪Mobilization of bound intracellular calcium from
sarcoplasmic reticulum to activate the contractile protein.
▪There is increase in frequency and force of uterine
contractions, similar to physiological uterine contractions
12
.
3
Physiological RoleBREAST
▪Role in milk ejection
▪Breast suckling and manipulation induces oxytocin release
▪Contractions of myo-epithelial cells surrounding alveolar cells in mammary gland forces milk into large collecting sinuses – milk ejection reflex
13 14
Oxytocin
Effects on other systems
CVS
Small doses cause vasodilatation producing
hypotension, reflex tachycardia and flushing.
Higher doses produce tachycardia and increased
cardiac output, marked constriction of umbilical
vessels, facilitating their closure at birth.
15
KIDNEYS
Higher doses (100 mIU) produce Anti-Diuretic Action
due to constriction of renal cortical vessels (in the
presence of estrogens)
Pulmonary oedema can get precipitated if large
amounts of IV fluids and oxytocin are infused together.
16
CNS
Appears to function as a peptide neurotransmitter in
hypothalamus and brainstem to regulate autonomic
neurons, can produce emotional behavior- maternal
bonding, adult bonding, role in autism (?).
17 18
.
4
Clinical uses of oxytocin
1. Induction of labor
a) To induce or augment labor in pregnant womenb) Premature rupture of membranesc) Intra uterine growth retardation (IUGR)d) Placental insufficiency – diabetes, preeclampsia or
eclampsia
Oxytocin is the drug of choice for induction of labor
19
Before induction, rule out:
1. Abnormal fetal position
2. Cephalo-pelvic disproportion (CPD)
3. Evidence of fetal distress
4. Placental abnormalities
5. Previous uterine surgery
20
Clinical uses of oxytocin – contd.
Oxytocin (Pitocin or Syntocinon)
▪ 10 IU is diluted in 1 L of 5% glucose or 0.9% saline – 10 milli IU/ml
▪ Start at low dose of 1-2ml/min and increase at 1 ml/min every 30-40 minutes
▪ Induces labor within 2 – 4 IU
▪ Higher doses are unsuccessful
▪ If labor starts– reduce the dose progressively
21
Oxytocin infusion Monitoring
▪Presence of Physician
▪Mother and fetus monitoring – fetal and maternal heart rate, maternal BP and strength of contractions
▪ If uterine hyper stimulation – discontinue infusion
▪Short half life – 6 to 12 minutes
▪Higher dose (more than 20 mu/min) may reduce water clearance – leading to water intoxication, coma and death
22
Clinical uses of oxytocin – contd.
2. Augmentation of labor
▪ In hypotonic contractions in dysfunctional labor (nulliparous) – administer as above
▪Normal progression of labor should never be tried to hasten, because over stimulation may cause:
a) Uterine rupture
b) Trauma to mother
c) Trauma to fetus
d) Compromised fetal oxygenation
e) Useful in prolonged latent phase of
f) Cervical dilation or arrest of dilation
23
Clinical uses of oxytocin – contd
3. Post partum haemorrhage, cesarean section:
▪5 IU IM or slow IV for immediate response
▪Especially useful in hypertensive women where ergometrine cannot be used
▪Also to maintain normal tone of uterine muscle
24
.
5
4. Breast engorgement:
▪Inefficient milk ejection reflex
▪Intranasal spray before suckling
Preparations:
▪Being a peptide not effective orally
▪Available as injections for IM and IV use – 0.5 ml, 1 ml and 5 ml etc.
25
Oxytocin
Indications for stopping the infusion
1. Abnormal uterine contractions
▪occurring too frequently ( less than every 2 minutes),
▪ lasting more than 60 seconds ( hyper stimulation)
▪ increased tonus in between the contraction
2. Evidence of fetal distress
3. Appearance of untoward maternal signs and symptoms
26
OxytocinDangers of Oxytocin
Maternal
1. Uterine hyper stimulation
2. Uterine rupture - high risk in grand multipara, malpresentation,
contracted pelvis, prior uterine scar and excessive dosages
3. Water intoxication - (high dosages i.e. 30 – 40 IU/min),
manifested by hyponatremia, confusion, convulsions, coma,
CHF and even death.
It can be prevented by strict I/O record, use of salt solutions, and
by avoiding high doses of oxytocin for a longer time.
27
4. Hypotension - it is seen with bolus IV injection especially
when the patient is hypovolemic or in patients with heart
disease. Occasionally may produce anginal pain.
5. Anti- diuresis - especially with higher dosages
Foetal
▪Foetal distress, foetal hypoxia or even foetal death may
occur due to reduced placental blood flow due to uterine
hyper stimulation.
28
Contraindications
1. Contracted pelvis
2. Malpresentation
3. Cephalopelvic disproportionation
4. Obstructed labour
5. History of LSCS
6. Hypovolemic states
7. Cardiac diseases
29
Carbetocin
▪A newer analogue of Oxytocin
▪Advantages are rapid onset and longer duration of action.
▪The half life is much longer (45 minutes) as compared to
oxytocin (4- 10 minutes).
▪Controls uterine atony in nearly 84 – 94 % patients.
▪Side effects - nausea, vomiting, diarrhea, headache,
hypertension and bronchospasm.
▪Should not be used in patients with CVS, pulmonary, hepatic
and renal diseases.
30
.
6
Vasopressin
▪Not commonly used as an oxytocic.
▪ It has more prominent oxytocic effect on non pregnant
uterus than oxytocin.
▪ Foetal hypoxia is a powerful stimulus for its release
31
Ergometrine & Methyl
ergometrine (Methergine)
32
Ergometrine & Methyl ergometrine(Methergine)
• Ergometrine, an alkaloid, isolated by Dudley and Moir,(1935)
from Ergot, derived from a fungus, Claviceps purpurea,
grows on rye, wheat, etc.
• Methergine is semi synthetic, derived from lysergic acid.
• Onset of action of ergometrine is quicker (45-60 secs) than
methergine (90 secs)
• Duration is similar (3hrs).
Ergot derivatives 33 34
Ergot derivatives
Pharmacological effects
▪Act directly on myometrium and cause tonic uterine contractions without any relaxation in between. Action is through the partial agonistic action on 5HT2 /α adr. receptors. Gravid uterus is more sensitive, esp. at term & early puerperium.
▪Should not be used for induction of labour/abortion, very effective for haemostasis, to stop bleeding from uterine sinuses following delivery/abortion.
35
▪GIT - Higher doses can increase peristalsis.
▪CVS effects - adrenergic agonists, cause
contractions of smooth muscles, both arterial and
venous vasoconstriction, increased PVR, CVP and
MAP.
36
.
7
Ergometrine - Uses
1. Postpartum haemorrhage: to prevent PPH
▪Used in dose of 0.2 to 0.3 mg IM immediately after delivery
of anterior shoulder
▪Continued for 4 - 7 days post partum
▪ If already PPH, use higher dose 0.5 mg IV
2. Caesarean section and instrumental delivery – to prevent
uterine atony
3. Subinvolution - 0.125 mg orally tds for 4 – 7 days
postpartum
37
Ergot derivatives
Adverse effects
▪ Nausea, vomiting , headache, pruritus, hypertension,
blurring of vision, dizziness, seizures, retinal detachment,
suppression of lactation and gangrene of toes after prolonged
use.
▪ Contraindicated in hypertensive patients and those with pre-
eclampsia
▪ Also contra-indicated during pregnancy or before the third
stage of labor.
38
Ergometrine
39
Why Oxytocin? Why not Ergometrine?
1. Short t ½-
2. Action can be easily terminated
3. Normal relaxation of uterus allowed-Good
fetal oxygenation
4. Lower segment not affected-descent free
5. More of physiological action
40
ERGOT OXYTOCIN
ERGOT VS OXYTOCIN
▪ Acts directly on
myometrium- tetanic, loss of
polarity
▪ Onset of action slow
▪ Duration of action is long
▪ ADR: increased BP &
gangrene
▪ CI: Eclampsia, Rh –ve, heart
disease
▪ Physiological contractions
,polarity is maintained.
▪ Onset is fast
▪ Duration of action is short
▪ ADR: rupture uterus &
hypotension
▪ CI: Grand multipara
41
Prostaglandins
42
.
8
Prostaglandins
▪PGE2 (Dinoprostone)→ Vaginal application → Induce II trimester
abortion, missed abortion, ripening of cervix in near term
▪ 15-Methyl-PGF2α (Carboprost)→ II trimester abortions
▪Misoprostol → with mifepristone for early abortion
43
Prostaglandins (PGs)
Pharmacological effects :
▪Contraction of smooth muscles of uterus, blood vessels, GIT
and bronchioles
Clinical effects:
▪Myometrial contraction
▪Softening and dilatation of cervix
▪ Inhibition of secretion of progesterone by corpus luteum.
▪Prior administration of mifepristone (anti-progestin drug)
sensitizes the uterus to the action of PGs.
44
Prostaglandins (PGs)
Pharmacokinetics:
▪Rapidly metabolized in lungs and liver.
▪About 90% inactivated in one circulation.
▪Given by intra vaginal, oral, rectal, intra muscular routes.
Prostin 15m (Carboprost) has longer duration of action.
45
Side effects:
▪Nausea, vomiting, diarrhea, fever, flushing and
bronchospasm.
▪CVS side effects: tachycardia, increased mean arterial
pressure and pulmonary artery pressure.
▪Use with caution in hypertension, diabetes, angina,
epilepsy and raised IOP.
▪Contraindicated in bronchial asthma, uterine scar, cardiac
renal or hepatic diseases.
46
Ethacridine
▪ It is an acridine compound.
▪ It is used intra-amniotically for second trimester
termination of pregnancy.
▪ It takes about 30 hours to effect the abortion.
▪Side effects are adverse GI effects, nausea and
vomiting etc.
47
Drug Regimen Side effects Contraindicatio
ns/Cautions
Oxytocin 5 IU in 500 ml
glucose/saline
(10mIU/ml infusion)
Vasodilatation,
Hypotension,
Tachycardia
Hypovolemia
Do not give undiluted
as an IV bolus
Methylergometrine 0.2-0.3 mg IM Vasoconstriction,
Hypertension,
Bradycardia
Hypertension,
Cardiac disease
15-methyl PGF2α
(Carboprost)
0.25 mg IM Bronchospasm,
Pulmonary edema
Cardiac, Renal,
Hepatic & Pulmonary
disorders
Misoprostol 200-400 µg
sublingual
800-100 µg per
rectal
Uterine scar
48
.
9
Uterine relaxants/Tocolytics
49
Tocolytics
▪Decrease uterine contractility/motility.
▪Used to delay/postpone labour, arrest threatened abortion & treatment of dysmenorrhea.
▪Suppression of labour
➢Allow the foetus to mature
➢Initiate glucocorticoid therapy for foetal lung maturation
➢Transfer the woman in labour to proper facilities
They are likely to succeed only if cervical dilatation is < 4 cm, taking up of the lower segment is minimal, effective in reducing the risk of delivery within 24 to 48 hours only.
50
Contraindications for tocolytics
1. More than 37 weeks gestation
2. Fetus >2500g
3. Fetus in distress
4. Cx dilation > 4 cm
5. Ruptured membrane
6. Toxemia
7. Cardiac diseases
8. PPH
51
Classification of Tocolytics
▪β2 adrenergic receptor agonists - Terbutaline,
Ritodrine, Isoxsuprine
▪Magnesium sulphate
▪Calcium channel blockers - Nifedipine & Nicardipine
▪Oxytocin receptor antagonist - Atosiban
▪Prostaglandin synthetase inhibitors - Indomethacin,
Aspirin, Ibuprofen, Sulindac
▪Nitric oxide donors - Nitroglycerine
▪Halothane
52
β 2 adrenergic receptor
agonists
53
β 2 adrenergic receptor agonists
▪ Terbutaline
▪Ritodrine
▪ Isoxsuprine
▪Mechanism of action - beta 2 receptor stimulation, causing smooth
muscle relaxation.
▪Used in uncomplicated premature labour between 24th to 33rd weeks
of gestation.
▪Continued for 12 hours after the contractions cease. Should not be
administered for more than 48 hours, as it can lead to increased risk
to the mother.
54
.
10
β 2 adrenergic receptor agonists
▪Side effects: Nausea, vomiting, tachycardia, palpitations,
headache, tremors, hypertension, pulmonary oedema,
CHF, arrhythmias, myocardial infarction, hyperglycemia,
hyperinsulinemia and hypokalemia.
Neonates may develop hypoglycemia and ileus.
55
Contraindications: 1. Diabetes mellitus
2. Cardiac disease
3. Patients on steroids
4. Patients on beta blockers
5. Patients on digitalis
6. Hyperthyroidism
7. Hypertension
56
Magnesium sulphate
57
Magnesium sulphate
▪ Acts by competitive inhibition of calcium ions at motor
endplates/cell membrane, reducing calcium influx.
▪Direct depressant action on uterine smooth muscle
▪ Infusion continued for 12 hours after cessation of contractions.
▪Magnesium sulphate by IV or inhalation route is also used in t/t
of acute severe asthma
58
Magnesium sulphate
Side effects:
▪ Nausea, vomiting, flushing, perspiration, headache,
drowsiness, respiratory depression, muscle weakness,
blurred vision and cardiac arrhythmias.
Foetal/ neonatal: Lethargy, hypotonia and respiratory
depression
Contraindications:
▪ Myasthenia gravis, heart blocks and renal disease.
59
Calcium Channel Blockers
60
.
11
Calcium Channel Blockers
Nifedipine & Nicardipine
▪Block the influx of calcium ions, thereby reducing the intra
cellular calcium, reduces the tone of myometrium & opposes
the contraction.
Side effects - Tachycardia, hypotension, headache, flushing,
nausea and peripheral oedema
Reduced placental perfusion may cause foetal hypoxia.
Contraindications - CHF, Hypotension, Aortic stenosis.
61
Oxytocin Receptor
antagonists
62
Oxytocin Receptor antagonists
Atosiban is a peptide analogue of oxytocin, acts as an
antagonist at oxytocin receptors.
▪ Side effects: nausea, vomiting, dyspnea, chest pain.
▪Contraindications: hepatic and renal disease.
63
Prostaglandin Sythesis inhibitors
Indomethacin, Aspirin, Ibuprofen and Sulindac
▪Maternal side effects: Headache, dizziness, nausea,
vomitting, diarrhea, haematemesis, and malena.
▪Foetal side effects: Oligohydraminos, premature closure of
Ductus arteriosus and necrotizing enterocolitis
▪Contraindications: Thrombocytopenia, bronchial asthma
and renal disease
64
OTHER AGENTS
▪Nitric Oxide Donors:
Nitroglycerine patches, not very reliable.
Side effects: tachycardia, hypertension and
methaemoglobinemia.
▪Halothane:
Very effective uterine relaxant has been used as
an anaesthetic for external/ internal versions &
manual removal of retained placenta
65
Oxytocics and Tocolytics
▪The most commonly administered drugs to the parturient and other obstetric patients
▪ The varied pharmacological actions of these drugs makes them of significant importance in obstetrics
66
.
12
Thank you67